Literature DB >> 17114148

Auditory discrimination therapy (ADT) for tinnitus managment: preliminary results.

C Herraiz1, I Diges, P Cobo, G Plaza, J M Aparicio.   

Abstract

CONCLUSION: This clinical assay has demonstrated the efficacy of auditory discrimination therapy (ADT) in tinnitus management compared with a waiting-list group. In all, 43% of the ADT patients improved their tinnitus, and its intensity together with its handicap were statistically decreased (EMB rating: B-2).
OBJECTIVE: To describe the effect of sound discrimination training on tinnitus. ADT designs a procedure to increase the cortical representation of trained frequencies (damaged cochlear areas with a secondary reduction of cortical stimulation) and to shrink the neighbouring over-represented ones (corresponding to tinnitus pitch). STUDY
DESIGN: This prospective descriptive study included 14 patients with high frequency matched tinnitus. Tinnitus severity was measured according to a visual analogue scale (VAS) and the Tinnitus Handicap Inventory (THI). Patients performed a 10-min auditory discrimination task twice a day for 1 month. Discontinuous 8 kHz pure tones were randomly mixed with 500 ms 'white noise' sounds through a MP3 system. ADT group results were compared with a waiting-list group (n=21).
RESULTS: In all, 43% of our patients had improvement in their tinnitus. A significant improvement in VAS (p=0.004) and THI mean scores was achieved (p=0.038). Statistical differences between ADT and the waiting-list group have been proved, considering patients' self-evaluations (p=0.043) and VAS scores (p=0.004). A non-significant reduction of THI was achieved (p=0.113).

Entities:  

Mesh:

Year:  2006        PMID: 17114148     DOI: 10.1080/03655230600895614

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  8 in total

1.  Individual Reliability of the Standard Clinical Method vs Patient-Centered Tinnitus Likeness Rating for Assessment of Tinnitus Pitch and Loudness Matching.

Authors:  Sylvie Hébert
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-12-01       Impact factor: 6.223

Review 2.  A multidisciplinary systematic review of the treatment for chronic idiopathic tinnitus.

Authors:  Hans-Peter Zenner; Wolfgang Delb; Birgit Kröner-Herwig; Burkhard Jäger; Ingrid Peroz; Gerhard Hesse; Birgit Mazurek; Gerhard Goebel; Christian Gerloff; Regina Trollmann; Eberhard Biesinger; Harald Seidler; Berthold Langguth
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-19       Impact factor: 2.503

Review 3.  S3 Guideline: Chronic Tinnitus : German Society for Otorhinolaryngology, Head and Neck Surgery e. V. (DGHNO-KHC).

Authors:  Birgit Mazurek; Gerhard Hesse; Heribert Sattel; Volker Kratzsch; Claas Lahmann; Christian Dobel
Journal:  HNO       Date:  2022-10-13       Impact factor: 1.330

Review 4.  The state of the art of sound therapy for subjective tinnitus in adults.

Authors:  Haiyan Wang; Dongmei Tang; Yongzhen Wu; Li Zhou; Shan Sun
Journal:  Ther Adv Chronic Dis       Date:  2020-09-14       Impact factor: 5.091

Review 5.  [Music therapy in chronic tonal tinnitus. Heidelberg model of evidence-based music therapy].

Authors:  H Argstatter; C Krick; H V Bolay
Journal:  HNO       Date:  2008-07       Impact factor: 1.284

Review 6.  Cortical reorganisation and tinnitus: principles of auditory discrimination training for tinnitus management.

Authors:  C Herraiz; I Diges; P Cobo; J M Aparicio
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-28       Impact factor: 2.503

7.  Effects of frequency discrimination training on tinnitus: results from two randomised controlled trials.

Authors:  Derek J Hoare; Victoria L Kowalkowski; Deborah A Hall
Journal:  J Assoc Res Otolaryngol       Date:  2012-04-04

8.  Gameplay as a source of intrinsic motivation in a randomized controlled trial of auditory training for tinnitus.

Authors:  Derek J Hoare; Nicolas Van Labeke; Abby McCormack; Magdalena Sereda; Sandra Smith; Hala Al Taher; Victoria L Kowalkowski; Mike Sharples; Deborah A Hall
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.